Although cell-autonomous pro-tumorigenic functions of mutant KRAS are well charted41–43, mechanisms utilized by the oncogene to co-opt host cells from the tumor microenvironment in order to favor tumor progression have only recently begun to be elucidated. The gene discussed is KRAS; the disease is neoplasm.